| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AEON Biopharma, Inc. | Director | Stock Option | 1,256,062 | 31 Aug 2024 | Direct | ||
| AEON Biopharma, Inc. | Director | Class A Common Stock | 750,547 | 31 Aug 2024 | Direct | ||
| AEON Biopharma, Inc. | Director | Restricted Stock Units | 370,370 | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AEON | AEON Biopharma, Inc. | 21 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 16:54 |
| AEON | AEON Biopharma, Inc. | 31 Aug 2024 | 2 | $0 | 4 | CHIEF EXECTUIVE OFFICER, Director | 04 Sep 2024, 21:59 |
| AEON | AEON Biopharma, Inc. | 19 Mar 2024 | 1 | $0 | 4 | CHIEF EXECTUIVE OFFICER, Director | 21 Mar 2024, 19:49 |
| AEON | AEON Biopharma, Inc. | 21 Jul 2023 | 6 | $0 | 4 | Chief Executive Officer, Director | 24 Jul 2023, 21:07 |
| AEON | AEON Biopharma, Inc. | 21 Jul 2023 | 0 | $0 | 3 | Chief Executive Officer, Director | 24 Jul 2023, 20:59 |